BIOREDUCTION-ACTIVATED COMPOUNDS, THEIR PRODRUGS, RADIOPHARMACEUTICAL PRODUCTS, COMPOSITIONS AND THEIR APPLICATIONS IN THE MULTIMODAL THERANOSTIC MANAGEMENT OF HYPOXIA, INCLUDING CANCER
The invention provides bioreduction-activated compounds, their prodrugs, radiopharmaceuticals, compositions, and their application in the multimodal theranostic management of hypoxia, including cancer.